Collplant Biotechnologies Ltd stock is traded at $3.91, with a volume of 22,143. It is down -8.97% in the last 24 hours and up +11.25% over the past month. CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
Previous Close:
$4.29
Open:
$4.15
24h Volume:
22,143
Relative Volume:
0.45
Market Cap:
$12.01M
Revenue:
$389.00K
Net Income/Loss:
-$13.13M
P/E Ratio:
-
EPS:
-$1.03
Net Cash Flow:
-$11.90M
1W Performance:
-4.99%
1M Performance:
+11.25%
6M Performance:
-2.91%
1Y Performance:
-80.08%
1-Day Range:
$3.86$4.15
1-Week Range:
$3.76$4.50
52-Week Range:
$2.64$22.50
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS